Cargando…

Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement

Carcinoembryonic antigen (CEA) is the best circulating tumour marker for colorectal liver metastasis (CLM) but has suboptimal sensitivity and specificity. Circulating type IV collagen (COLIV) is a new potential CLM marker. Here, COLIV and CEA were measured in patients with resectable CLM. COLIV leve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nyström, Hanna, Tavelin, Björn, Björklund, Moa, Naredi, Peter, Sund, Malin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689748/ https://www.ncbi.nlm.nih.gov/pubmed/26162539 http://dx.doi.org/10.1007/s13277-015-3729-z

Ejemplares similares

Type IV collagen as a potential biomarker of metastatic breast cancer
por: Lindgren, Moa, et al.
Publicado: (2021)

Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer
por: Öhlund, D, et al.
Publicado: (2009)

Type IV Collagen in Human Colorectal Liver Metastases—Cellular Origin and a Circulating Biomarker
por: Lindgren, Moa, et al.
Publicado: (2022)

Prognostic Value of Stromal Type IV Collagen Expression in Small Invasive Breast Cancers
por: Jansson, Malin, et al.
Publicado: (2022)

Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop
por: Öhlund, Daniel, et al.
Publicado: (2013)

A Cross-Sectional and Longitudinal Analysis of Pre-Diagnostic Blood Plasma Biomarkers for Early Detection of Pancreatic Cancer
por: Mason, James, et al.
Publicado: (2022)

Influence of primary tumour and patient factors on survival in patients undergoing curative resection and treatment for liver metastases from colorectal cancer
por: Scherman, P., et al.
Publicado: (2019)

The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer.
por: Ward, U., et al.
Publicado: (1993)

Multimodal CEA-targeted fluorescence and radioguided cytoreductive surgery for peritoneal metastases of colorectal origin
por: de Gooyer, Jan Marie, et al.
Publicado: (2022)

Relationship of serum CEA levels to tumour size and CEA content in nude mice bearing colonic-tumour xenografts.
por: Lewis, J. C., et al.
Publicado: (1981)

Significance of CEA and VEGF as Diagnostic Markers of Colorectal Cancer in Lebanese Patients
por: Dbouk, Hashem A., et al.
Publicado: (2007)

The site of binding of anti-CEA antibodies to tumour CEA in vivo: an immunocytochemical and autoradiographic approach.
por: Moshakis, V., et al.
Publicado: (1982)

The clinical experience of the prognosis in opposite CEA and image change after therapy in stage IV colorectal cancer
por: Su, Yi-Tien, et al.
Publicado: (2022)

Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment
por: Bartsch, Rupert, et al.
Publicado: (2006)

The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model.
por: Pedley, R. B., et al.
Publicado: (1989)

Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma
por: Vukobrat-Bijedic, Zora, et al.
Publicado: (2013)

Immunological comparison of carcinoembryonic antigen (CEA) extracted from tumours of various organs: their use in radioimmunological CEA determinations.
por: Lamerz, R., et al.
Publicado: (1983)

Involvement of circulating CEA in liver metastases from colorectal cancers re-examined in a new experimental model
por: Leconte, A, et al.
Publicado: (1999)

Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.
por: Haglund, C.
Publicado: (1986)

Use of cholesterol and soluble tumour markers CEA and syndecan-2 in pleural effusions in cases of inconclusive cytology
por: Gulyas, Miklos, et al.
Publicado: (2019)

Decentralized colonoscopic surveillance with high patient compliance prevents hereditary and familial colorectal cancer
por: Sjöström, Olle, et al.
Publicado: (2016)

Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases
por: Nicolini, Andrea, et al.
Publicado: (2006)

The prognostic value of the postoperative serum CEA levels/preoperative serum CEA levels ratio in colorectal cancer patients with high preoperative serum CEA levels
por: Xie, Hai-Lun, et al.
Publicado: (2019)

CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids
por: Gonzalez-Exposito, Reyes, et al.
Publicado: (2019)

Tumour lysis as a factor affecting blood levels of CEA.
por: Quayle, J. B.
Publicado: (1982)

The Level of Preoperative Plasma KRAS Mutations and CEA Predict Survival of Patients Undergoing Surgery for Colorectal Cancer Liver Metastases
por: Polivka, Jiri, et al.
Publicado: (2020)

Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers
por: Palmqvist, R, et al.
Publicado: (1999)

Plasma CEA in the post-surgical monitoring of colorectal carcinoma.
por: Tate, H.
Publicado: (1982)

Collagen IV of basement membranes: IV. Adaptive mechanism of collagen IV scaffold assembly in Drosophila
por: Summers, Jacob A., et al.
Publicado: (2023)

Serum CEA testing in the post-operative surveillance of colorectal carcinoma.
por: Hine, K. R., et al.
Publicado: (1984)

Preoperative serum levels of CEA and CA 242 in colorectal cancer.
por: Carpelan-Holmström, M., et al.
Publicado: (1995)

Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases.
por: Kuusela, P., et al.
Publicado: (1987)

CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA.
por: Haglund, C., et al.
Publicado: (1994)

Postoperative carcinoembryonic antigen (CEA) levels predict outcomes after resection of colorectal cancer in patients with normal preoperative CEA levels
por: Zhang, Chiming, et al.
Publicado: (2020)

Sensitivity of Symptomatology Versus Diagnostic Procedures and Concentration of CEA and CA19–9 in the Early Detection of Colorectal Cancer
por: Vukobrat-Bijedic, Zora, et al.
Publicado: (2014)

Sex Differences in Glioblastoma—Findings from the Swedish National Quality Registry for Primary Brain Tumors between 1999–2018
por: Tavelin, Björn, et al.
Publicado: (2022)

Circulating markers of collagen types I, III, and IV in patients with dilated cardiomyopathy: relationships with myocardial collagen expression
por: Nagao, Kazuya, et al.
Publicado: (2018)

CEA solenoide
por: Sylvie Prodon
Publicado: (2003)

Receptor conversion and survival in breast cancer liver metastases
por: Sundén, Marcus, et al.
Publicado: (2023)

Matrix Metalloproteinase 8 Expression in a Tumour Predicts a Favourable Prognosis in Pancreatic Ductal Adenocarcinoma
por: Kaasinen, Mirjami, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ju5r5p2lcf48kkovt3p8mtrp1t